According to the new market research report “Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region – Global Forecast to 2024” published by MarketsandMarkets™.The Global Cardiac Mapping Market size is expected to grow from USD 1.4 billion in 2019 to USD 2.1 billion by 2024, at a CAGR of 8.7% during the forecast period.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market.

These methods were also used extensively to determine the extent of various subsegments in the market.

The research methodology used to estimate the market size includes the following:– The key players in the industry and markets have been identified through extensive secondary research– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405Contact cardiac mapping are estimated to account for the largest share of the cardiac mapping systems product market in 2019The contact cardiac mapping market is segmented into contact cardiac mapping systems and non-contact cardiac mapping systems.

The contact cardiac mapping systems segment is divided further into electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping.

The contact cardiac mapping systems segment held the largest share of the cardiac mapping systems market in 2019.

The advantages offered by contact cardiac mapping systems, such as detection of the precise locations of mapping and ablation catheters in a three-dimensional environment and requirement of just a few beats recordings might uncover the arrhythmia circuit, are the major factors driving the growth of this product segment.Atrial fibrillation is the primary application areas of the global cardiac mapping marketThe market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias.

The report “Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region – Global Forecast to 2024″, the Cardiac Mapping System Market is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.The Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market.

The research methodology used to estimate the market size includes the following:– The key players in the industry and markets have been identified through extensive secondary research– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405Atrial fibrillation is the primary application areas of the global cardiac mapping marketThe market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias.

The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.Geographical View in-detailed:North America held the largest share of the market in 2019 and is projected to continue to do so during the forecast period.

Factors such as the increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, growing focus of government organizations on providing funding for research, and increasing geriatric population in Canada are driving the North American cardiac mapping market.Key Market Players;The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US).

These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence.

The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405Biosense Webster (US) held the dominant position in the cardiac mapping market in 2018.

The report “Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region – Global Forecast to 2024″, the Cardiac Mapping System Market is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.The Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market.

The research methodology used to estimate the market size includes the following:– The key players in the industry and markets have been identified through extensive secondary research– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405Atrial fibrillation is the primary application areas of the global cardiac mapping marketThe market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias.

The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.Geographical View in-detailed:North America held the largest share of the market in 2019 and is projected to continue to do so during the forecast period.

Factors such as the increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, growing focus of government organizations on providing funding for research, and increasing geriatric population in Canada are driving the North American cardiac mapping market.Key Market Players;The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US).

These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence.

The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405Biosense Webster (US) held the dominant position in the cardiac mapping market in 2018.